Institutionellt ägande och fondägande - Köpare
Större innehavare som har öppnat nya positioner i Mereo BioPharma Group plc - Depositary Receipt (Common Stock) inkluderar FBTAX - Fidelity Advisor Biotechnology Fund Class A, Paloma Partners Management Co, Millennium Management Llc, Dauntless Investment Group, LLC, LMR Partners LLP, Nomura Holdings Inc, DLD Asset Management, LP, Exome Asset Management LLC, Marex Group plc, Raymond James Financial Inc, Skopos Labs, Inc., och EverSource Wealth Advisors, LLC .
Denna sida visar förändringar i ägarstrukturen genom att lista institutioner, fonder och större aktieägare som har ökat sina innehav eller öppnat nya positioner under den senaste rapporteringsperioden. Gröna rader indikerar nya positioner. Klicka på länk symbolen för att se hela transaktionshistoriken.
Uppgradera för att låsa upp premiumdata.
Fil Datum | Källa | Investerare | Typ | Genomsnittligt pris (beräknat) |
Aktier | Δ Aktier (%) |
Rapporterat värde (1000 USD) |
Δ Värde (%) |
Portföljallokering (%) |
|
---|---|---|---|---|---|---|---|---|---|---|
2025-08-13 | 13F | Renaissance Technologies Llc | 1 480 471 | 9,63 | 4 012 | 32,06 | ||||
2025-08-14 | 13F/A | Skopos Labs, Inc. | 849 | 2 | ||||||
2025-08-14 | 13F | Cubist Systematic Strategies, LLC | 21 099 | 57 | ||||||
2025-08-07 | 13F | Allworth Financial LP | 1 637 | 9,13 | 4 | 33,33 | ||||
2025-08-11 | 13F | Principal Securities, Inc. | 75 | 134,38 | 0 | |||||
2025-08-11 | 13F | Persistent Asset Partners Ltd | Call | 3 035 | 155,90 | 244 | 65,31 | |||
2025-07-14 | 13F | Avanza Fonder AB | 38 235 | 35,97 | 104 | 56,06 | ||||
2025-08-28 | NP | Tekla World Healthcare Fund | 1 681 804 | 29,33 | 4 558 | 55,79 | ||||
2025-07-31 | 13F | Caitong International Asset Management Co., Ltd | 4 544 | 206,20 | 12 | 300,00 | ||||
2025-08-12 | 13F | XTX Topco Ltd | 69 341 | 188 | ||||||
2025-08-14 | 13F | LMR Partners LLP | Call | 125 000 | 339 | |||||
2025-08-14 | 13F | Millennium Management Llc | Call | 153 000 | 415 | |||||
2025-08-19 | 13F | Newbridge Financial Services Group, Inc. | 13 000 | 18,18 | 35 | 45,83 | ||||
2025-08-19 | 13F | Marex Group plc | 10 000 | 27 | ||||||
2025-08-14 | 13F | Diadema Partners Lp | Call | 1 317 600 | 155,75 | 3 571 | 208,02 | |||
2025-08-14 | 13F | Two Sigma Advisers, Lp | 144 600 | 393,52 | 392 | 501,54 | ||||
2025-08-14 | 13F | Citadel Advisors Llc | 760 659 | 121,35 | 2 061 | 166,62 | ||||
2025-08-14 | 13F | Citadel Advisors Llc | Put | 99 800 | 187,61 | 270 | 246,15 | |||
2025-08-14 | 13F | Caption Management, LLC | 197 599 | 88,58 | 535 | 127,66 | ||||
2025-08-14 | 13F | Caption Management, LLC | Call | 437 500 | 43,44 | 1 186 | 72,74 | |||
2025-07-14 | 13F | GAMMA Investing LLC | 9 257 | 10,47 | 25 | 38,89 | ||||
2025-08-14 | 13F | Millennium Management Llc | 595 673 | 51,02 | 1 614 | 81,96 | ||||
2025-08-14 | 13F | Point72 Asset Management, L.P. | 59 200 | 65,29 | 160 | 100,00 | ||||
2025-08-14 | 13F | Jane Street Group, Llc | Call | 27 000 | 126,89 | 73 | 180,77 | |||
2025-08-14 | 13F | Jane Street Group, Llc | 247 441 | 70,88 | 671 | 106,15 | ||||
2025-08-14 | 13F | Frazier Life Sciences Management, L.P. | 9 440 112 | 20,72 | 25 583 | 45,40 | ||||
2025-08-14 | 13F | Susquehanna International Group, Llp | 361 542 | 107,33 | 980 | 149,74 | ||||
2025-08-14 | 13F | Susquehanna International Group, Llp | Call | 133 600 | 43,66 | 362 | 73,21 | |||
2025-08-14 | 13F | Susquehanna International Group, Llp | Put | 111 600 | 27,11 | 302 | 53,30 | |||
2025-08-14 | 13F | Dauntless Investment Group, LLC | 134 122 | 363 | ||||||
2025-08-28 | NP | Tekla Life Sciences Investors | 1 347 068 | 65,88 | 3 651 | 99,78 | ||||
2025-08-14 | 13F | Raymond James Financial Inc | 1 570 | 4 | ||||||
2025-08-12 | 13F | Proequities, Inc. | Put | 0 | 0 | |||||
2025-08-12 | 13F | Proequities, Inc. | Call | 0 | 0 | |||||
2025-08-12 | 13F | Proequities, Inc. | 0 | 0 | ||||||
2025-08-14 | 13F | Fmr Llc | 1 478 500 | 94,77 | 4 007 | 134,68 | ||||
2025-08-14 | 13F | Jane Street Group, Llc | Put | 221 700 | 2,02 | 601 | 22,95 | |||
2025-06-26 | NP | FBTAX - Fidelity Advisor Biotechnology Fund Class A This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 759 100 | 1 966 | ||||||
2025-08-13 | 13F | Quadrature Capital Ltd | 25 399 | 11,95 | 69 | 35,29 | ||||
2025-08-14 | 13F | Clearline Capital LP | 3 618 163 | 12,44 | 9 805 | 35,43 | ||||
2025-09-04 | 13F/A | Advisor Group Holdings, Inc. | 5 377 | 75,55 | 15 | 133,33 | ||||
2025-07-16 | 13F | Signaturefd, Llc | 187 | 1 | ||||||
2025-08-08 | 13F | Geode Capital Management, Llc | 92 534 | 0,41 | 251 | 20,77 | ||||
2025-08-12 | 13F | Rhumbline Advisers | 9 878 | 49,94 | 27 | 85,71 | ||||
2025-08-27 | 13F/A | Squarepoint Ops LLC | 20 668 | 15,26 | 56 | 40,00 | ||||
2025-08-14 | 13F | Two Sigma Investments, Lp | 659 158 | 168,82 | 1 786 | 224,14 | ||||
2025-08-14 | 13F | Aquatic Capital Management LLC | 26 930 | 73 | ||||||
2025-08-15 | 13F/A | Exome Asset Management LLC | 14 600 | 40 | ||||||
2025-08-05 | 13F | Simplex Trading, Llc | Put | 25 000 | 7,76 | 0 | ||||
2025-08-05 | 13F | Simplex Trading, Llc | 201 141 | 4 785,62 | 1 | |||||
2025-08-05 | 13F | Simplex Trading, Llc | Call | 199 200 | 250,09 | 1 | ||||
2025-07-14 | 13F | HealthInvest Partners AB | 764 901 | 96,13 | 2 073 | 136,26 | ||||
2025-08-12 | 13F | BlackRock, Inc. | 455 365 | 65,97 | 1 234 | 100,00 | ||||
2025-07-24 | 13F | Standard Life Aberdeen plc | 3 028 872 | 38,41 | 8 208 | 66,73 | ||||
2025-08-14 | 13F | Group One Trading, L.p. | Call | 489 900 | 13,25 | 1 328 | 36,38 | |||
2025-08-18 | 13F/A | Nomura Holdings Inc | 125 000 | 339 | ||||||
2025-07-15 | 13F | Significant Wealth Partners LLC | 22 261 | 61,65 | 60 | 100,00 | ||||
2025-08-14 | 13F | Goldman Sachs Group Inc | 3 090 068 | 45,35 | 8 374 | 75,08 | ||||
2025-08-14 | 13F | Group One Trading, L.p. | 139 559 | 307,10 | 378 | 390,91 | ||||
2025-08-14 | 13F | Paloma Partners Management Co | 296 659 | 804 | ||||||
2025-08-11 | 13F | Persistent Asset Partners Ltd | Put | 2 303 | 2 430,77 | 1 025 | 14 542,86 | |||
2025-08-13 | 13F/A | DLD Asset Management, LP | Call | 25 000 | 68 | |||||
2025-06-25 | NP | BBC - Virtus LifeSci Biotech Clinical Trials ETF | 44 024 | 170,19 | 114 | 132,65 | ||||
2025-08-13 | 13F | EverSource Wealth Advisors, LLC | 470 | 1 | ||||||
2025-08-14 | 13F | Artia Global Partners LP | 475 361 | 12,82 | 1 288 | 35,86 |